StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Idiots

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron May 17, 2021 9:32am

196 Views

Post# 33213191

Idiots

On this board it's no wonder no one asked questions. The company had 2.5 million in revenue with less than 2 million in admin costs almost $7 million still in the bank. Covid pretty much finding 100% of the operation and not touching the bank account

any loss was for valuation of warrants which is just on paper.

if you can't understand how the company is now finding operations while rolling out Aristotle. Sell and move on.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec